Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2017

Jul 5, 2017

34975_dirs_2017-07-05_021ef885-1d9a-40ae-8a80-8bb9a8705468.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2017-07-01

Reporting Person: LOY BERTRAND (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-07-01 Common Stock A 950 $0.00 Acquired 102750 Direct

Footnotes

F1: Represents a deferred stock award of 950 restricted stock units which vest quarterly in equal installments on September 30, 2017 and December 31, 2017. This retainer award was granted in lieu and satisfaction of the annual cash retainer compensation to be earned by the director for his service on a committee of the Issuer's Board of Directors that the reporting person was appointed to following the 2017 annual meeting of stockholders. The number of shares of common stock subject to such retainer award is equal to the amount of cash that would have been received had the applicable retainer all been paid in cash, divided by the average daily closing market price of the Issuer's common stock for the month of April, rounded to the nearest 100 shares.

F2: Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 9,750 restricted stock units which vest quarterly in equal installments on September 30, 2017 and December 31, 2017; and (c) 61,700 shares of common stock held by the Reporting Person.